Cellosaurus cell line M311 [Human melanoma] (CVCL

Cross-references
Cell line name	M311 [Human melanoma]
Accession	CVCL_B4KR
Resource Identification Initiative	To cite this cell line use: M311 [Human melanoma] (RRID:CVCL_B4KR)
Sequence variations	Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Homozygous (PubMed=25645078; PubMed=27533468).
Disease	Melanoma (NCIt: C3224)
Species of origin	Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell	Sex unspecified
Age at sampling	Age unspecified
Category	Cancer cell line
Publications	PubMed=25645078; DOI=10.1186/s12943-015-0293-5; PMCID=PMC4320814 Atefi M., Titz B., Avramis E., Ng C., Wong D.J.L., Lassen A., Cerniglia M., Escuin-Ordinas H., Foulad D., Comin-Anduix B., Graeber T.G., Ribas A. Combination of pan-RAF and MEK inhibitors in NRAS mutant melanoma. Mol. Cancer 14:27.1-27.12(2015) PubMed=27533468; DOI=10.1080/15384101.2016.1208862; PMCID=PMC5026796 Malka-Mahieu H., Girault I., Rubington M., Leriche M., Welsch C., Kamsu-Kom N., Zhao Q., Desaubry L., Vagner S., Robert C. Synergistic effects of eIF4A and MEK inhibitors on proliferation of NRAS-mutant melanoma cell lines. Cell Cycle 15:2405-2409(2016)
Cell line databases/resources	cancercelllines; CVCL_B4KR
Encyclopedic resources	Wikidata; Q110433010
Entry history
Entry creation	16-Dec-2021
Last entry update	19-Dec-2024
Version number	5